Andrew D. Dickinson - 10 Mar 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Financial Officer
Signature
/s/ Amy Kim by Power of Attorney for Andrew D. Dickinson
Issuer symbol
GILD
Transactions as of
10 Mar 2026
Net transactions value
$0
Form type
4
Filing time
12 Mar 2026, 16:45:40 UTC
Previous filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dickinson Andrew D Chief Financial Officer GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Amy Kim by Power of Attorney for Andrew D. Dickinson 12 Mar 2026 0001310204

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +6,469 +3.6% 185,338 10 Mar 2026 Direct F1
transaction GILD Common Stock Tax liability -3,147 -1.7% $148.56* 182,191 10 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -6,469 -24% 21,057 10 Mar 2026 Common Stock 6,469 Direct F1, F2
transaction GILD Restricted Stock Unit Award +9,590 +46% 30,647 10 Mar 2026 Common Stock 9,590 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award +35,880 $0.000000* 35,880 10 Mar 2026 Common Stock 35,880 $148.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The stock options have a four-year vesting schedule. 25% vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.